These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 10096294)

  • 1. Engineering receptor-mediated cytotoxicity into human ribonucleases by steric blockade of inhibitor interaction.
    Suzuki M; Saxena SK; Boix E; Prill RJ; Vasandani VM; Ladner JE; Sung C; Youle RJ
    Nat Biotechnol; 1999 Mar; 17(3):265-70. PubMed ID: 10096294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational analysis of the complex of human RNase inhibitor and human eosinophil-derived neurotoxin (RNase 2).
    Teufel DP; Kao RY; Acharya KR; Shapiro R
    Biochemistry; 2003 Feb; 42(6):1451-9. PubMed ID: 12578357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the N terminus in RNase A homologues: differences in catalytic activity, ribonuclease inhibitor interaction and cytotoxicity.
    Boix E; Wu Y; Vasandani VM; Saxena SK; Ardelt W; Ladner J; Youle RJ
    J Mol Biol; 1996 Apr; 257(5):992-1007. PubMed ID: 8632481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tandemization endows bovine pancreatic ribonuclease with cytotoxic activity.
    Leich F; Köditz J; Ulbrich-Hofman R; Arnold U
    J Mol Biol; 2006 May; 358(5):1305-13. PubMed ID: 16580680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular recognition of human eosinophil-derived neurotoxin (RNase 2) by placental ribonuclease inhibitor.
    Iyer S; Holloway DE; Kumar K; Shapiro R; Acharya KR
    J Mol Biol; 2005 Apr; 347(3):637-55. PubMed ID: 15755456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption of shape-complementarity markers to create cytotoxic variants of ribonuclease A.
    Rutkoski TJ; Kurten EL; Mitchell JC; Raines RT
    J Mol Biol; 2005 Nov; 354(1):41-54. PubMed ID: 16188273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing the potency of a cytotoxin with an arginine graft.
    Fuchs SM; Rutkoski TJ; Kung VM; Groeschl RT; Raines RT
    Protein Eng Des Sel; 2007 Oct; 20(10):505-9. PubMed ID: 17954521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An insertion in loop L7 of human eosinophil-derived neurotoxin is crucial for its antiviral activity.
    Sikriwal D; Seth D; Parveen S; Malik A; Broor S; Batra JK
    J Cell Biochem; 2012 Oct; 113(10):3104-12. PubMed ID: 22581709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiogenin single-chain immunofusions: influence of peptide linkers and spacers between fusion protein domains.
    Newton DL; Xue Y; Olson KA; Fett JW; Rybak SM
    Biochemistry; 1996 Jan; 35(2):545-53. PubMed ID: 8555226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of catalytic and non-catalytic subsite residues in ribonuclease activity of human eosinophil-derived neurotoxin.
    Sikriwal D; Seth D; Batra JK
    Biol Chem; 2009 Mar; 390(3):225-34. PubMed ID: 19090717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insertional-fusion of basic fibroblast growth factor endowed ribonuclease 1 with enhanced cytotoxicity by steric blockade of inhibitor interaction.
    Tada H; Onizuka M; Muraki K; Masuzawa W; Futami J; Kosaka M; Seno M; Yamada H
    FEBS Lett; 2004 Jun; 568(1-3):39-43. PubMed ID: 15196917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of RNase A tandem enzymes and their interaction with the cytosolic ribonuclease inhibitor.
    Arnold U; Leich F; Neumann P; Lilie H; Ulbrich-Hofmann R
    FEBS J; 2011 Jan; 278(2):331-40. PubMed ID: 21134128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloning and cytotoxicity of a human pancreatic RNase immunofusion.
    Zewe M; Rybak SM; Dübel S; Coy JF; Welschof M; Newton DL; Little M
    Immunotechnology; 1997 Jun; 3(2):127-36. PubMed ID: 9237097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxicity of bovine seminal ribonuclease: monomer versus dimer.
    Lee JE; Raines RT
    Biochemistry; 2005 Dec; 44(48):15760-7. PubMed ID: 16313179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards the rational design of antimicrobial proteins: single point mutations can switch on bactericidal and agglutinating activities on the RNase A superfamily lineage.
    Pulido D; Moussaoui M; Nogués MV; Torrent M; Boix E
    FEBS J; 2013 Nov; 280(22):5841-52. PubMed ID: 23992292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Both aromatic and cationic residues contribute to the membrane-lytic and bactericidal activity of eosinophil cationic protein.
    Carreras E; Boix E; Rosenberg HF; Cuchillo CM; Nogués MV
    Biochemistry; 2003 Jun; 42(22):6636-44. PubMed ID: 12779318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Origin of dimeric structure in the ribonuclease superfamily.
    Ciglic MI; Jackson PJ; Raillard SA; Haugg M; Jermann TM; Opitz JG; Trabesinger-Rüf N; Benner SA
    Biochemistry; 1998 Mar; 37(12):4008-22. PubMed ID: 9521722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Degradation of double-stranded RNA by human pancreatic ribonuclease: crucial role of noncatalytic basic amino acid residues.
    Sorrentino S; Naddeo M; Russo A; D'Alessio G
    Biochemistry; 2003 Sep; 42(34):10182-90. PubMed ID: 12939146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of a human ribonuclease inhibitor variant in Escherichia coli and silkworm insect cell (Bombyx mori)].
    Huang GH; Yang GZ; Chen JY; Wu XF
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Oct; 35(10):960-3. PubMed ID: 14515218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-dimensional structure of a human pancreatic ribonuclease variant, a step forward in the design of cytotoxic ribonucleases.
    Pous J; Canals A; Terzyan SS; Guasch A; Benito A; Ribó M; Vilanova M; Coll M
    J Mol Biol; 2000 Oct; 303(1):49-60. PubMed ID: 11021969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.